Patient Engagement Suite
-
Flexible IRT Platform Solution For National Lung Cancer Trial
2/24/2021
Trial design for a medicine trial to investigate treatment for non-small cell lung cancer presents unique challenges. These include the need for an IRT platform that can support the rapid incorporation of amendments and account for multiple or potential arms requiring different lists of material types and dosages that could be prescribed to patients and supplied to sites. Cenduit’s highly-configurable, flexible technology platform was the solution.
-
Navigating Patient Consent Scenarios In COVID-19 Trials
5/20/2020
Many people have questions on the topic of remote consent in a hospital setting, particularly when the patient is quite ill and requires a legally acceptable representative (LAR) to consent on his or her behalf. This article shares insights gained through real-world implementations of remote consent.
-
Five Frequently Asked Questions (And Answers) About eConsent During The COVID-19 Crisis
4/17/2020
For the clinical research industry, COVID-19 poses immediate and long-term challenges that require sharing experiences with the industry now more than ever. This article provides the most frequently asked questions about eConsent technology.
-
Patient Data: The Backbone Of Your Clinical Trial
In clinical trials, data capture is typically centered around patients’ experiences with a drug. See why electronic clinical outcome assessments (eCOAs) are essential to patient data capture.
-
Improving Supply Chain: Accountability, Sustainability, Optimization
Watch as industry experts explore the advancements in drug accountability facilitated through IRT, encompassing innovative methods for managing site variations and sustainable supply chains.